Abstract
Gliomas are the most common form of primary brain tumors and are associated with a poor clinical outcome. The molecular mechanisms that contribute to gliomagenesis have become increasingly clear in recent years, yet much remains to be learned. This is particularly true for the role of microRNAs in gliomagenesis, as an appreciation for the significance of aberrant miRNA expression in human cancer has only emerged in the last 5 years. It is now evident that microRNAs regulate a wide variety of tumorigenic processes including cellular proliferation, differentiation, angiogenesis, invasion, and apoptosis. Here we review the current state of knowledge related to the role of microRNAs in glial tumor development. This is a rapidly evolving field and it is likely that we have only begun to appreciate the involvement of microRNAs in relation to glioma formation, and the therapeutic potential of microRNAs to improve outcome for glioma patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alcantara Llaguno, S., Chen, J., Kwon, C. H., Jackson, E. L., Li, Y., Burns, D. K., et al. (2009). Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell, 15, 45–56.
Aoki, H., Yokoyama, T., Fujiwara, K., Tari, A. M., Sawaya, R., Suki, D., et al. (2007). Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma. Clinical Cancer Research, 13, 6603–6609.
Argyriou, A. A., Giannopoulou, E., & Kalofonos, H. P. (2009). Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas. Oncology, 77, 1–11.
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756–760.
Birner, P., Gatterbauer, B., Oberhuber, G., Schindl, M., Rossler, K., Prodinger, A., et al. (2001). Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer, 92, 165–171.
Camps, C., Buffa, F. M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., et al. (2008). hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research, 14, 1340–1348.
Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394, 485–490.
Cavalla, P., Piva, R., Bortolotto, S., Grosso, R., Cancelli, I., Chio, A., et al. (1999). P27/kip1 expression in oligodendrogliomas and its possible prognostic role. Acta Neuropathologica, 98, 629–634.
Chalhoub, N., & Baker, S. J. (2009). PTEN and the PI3-kinase pathway in cancer. Annual Review of Pathology, 4, 127–150.
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research, 65, 6029–6033.
Chen, X., Guo, X., Zhang, H., Xiang, Y., Chen, J., Yin, Y., et al. (2009). Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 28, 1385–1392.
Chen, Y., Liu, W., Chao, T., Zhang, Y., Yan, X., Gong, Y., et al. (2008). MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Letters, 272, 197–205.
Cheng, A. M., Byrom, M. W., Shelton, J., & Ford, L. P. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research, 33, 1290–1297.
Ciafre, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C. G., Sabatino, G., et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and Biophysical Research Communications, 334, 1351–1358.
Conaco, C., Otto, S., Han, J. J., & Mandel, G. (2006). Reciprocal actions of REST and a microRNA promote neuronal identity. Proceedings of the National Academy of Sciences, USA, 103, 2422–2427.
Conti, A., Aguennouz, M., La Torre, D., Tomasello, C., Cardali, S., Angileri, F. F., et al. (2009). miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors. Journal of Neurooncology, 93, 325–332.
Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007). MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Research, 67, 8994–9000.
De Pietri Tonelli, D., Pulvers, J. N., Haffner, C., Murchison, E. P., Hannon, G. J., & Huttner, W. B. (2008). miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development, 135, 3911–3921.
DeGregori, J. (2002). The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochimica et Biophysica Acta, 1602, 131–150.
Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., et al. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics, 38, 1060–1065.
Du, R., Petritsch, C., Lu, K., Liu, P., Haller, A., Ganss, R., et al. (2008). Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro-Oncology, 10, 254–264.
Ekholm, S. V., & Reed, S. I. (2000). Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Current Opinion in Cell Biology, 12, 676–684.
Elias, M. C., Tozer, K. R., Silber, J. R., Mikheeva, S., Deng, M., Morrison, R. S., et al. (2005). TWIST is expressed in human gliomas and promotes invasion. Neoplasia, 7, 824–837.
Ewan, L. C., Jopling, H. M., Jia, H., Mittar, S., Bagherzadeh, A., Howell, G. J., et al. (2006). Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic, 7, 1270–1282.
Fasanaro, P., D’Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., et al. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry, 283, 15878–15883.
Fasano, C. A., Dimos, J. T., Ivanova, N. B., Lowry, N., Lemischka, I. R., & Temple, S. (2007). shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell, 1, 87–99.
Fischer, I., Gagner, J. P., Law, M., Newcomb, E. W., & Zagzag, D. (2005). Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathology, 15, 297–310.
Foshay, K. M., & Gallicano, G. I. (2007). Small RNAs, big potential: The role of MicroRNAs in stem cell function. Current Stem Cell Research & Therapy, 2, 264–271.
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes and Development, 21, 2683–2710.
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Molecular and Cellular Biology, 28, 5369–5380.
Galardi, S., Mercatelli, N., Giorda, E., Massalini, S., Frajese, G. V., Ciafre, S. A., et al. (2007). miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. Journal of Biological Chemistry, 282, 23716–23724.
Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., Chen, C., et al. (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Research, 67, 2456–2468.
Giaccia, A., Siim, B. G., & Johnson, R. S. (2003). HIF-1 as a target for drug development. Nature Reviews Drug Discovery, 2, 803–811.
Gillies, J. K., & Lorimer, I. A. (2007). Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle, 6, 2005–2009.
Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Research, 68, 9125–9130.
Guo, C., Sah, J. F., Beard, L., Willson, J. K., Markowitz, S. D., & Guda, K. (2008). The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer, 47, 939–946.
Guo, W. J., Zeng, M. S., Yadav, A., Song, L. B., Guo, B. H., Band, V., et al. (2007). Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Research, 67, 5083–5089.
Hashizume, R., Ozawa, T., Gryaznov, S. M., Bollen, A. W., Lamborn, K. R., Frey II, W. H., et al. (2008). New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163. Neuro-Oncology, 10, 112–120.
Hayes, M. E., Drummond, D. C., Hong, K., Zheng, W. W., Khorosheva, V. A., Khorosheva, V. A., et al. (2006a). Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation. Molecular Pharmacology, 3, 726–736.
Hayes, M. E., Drummond, D. C., Kirpotin, D. B., Zheng, W. W., Noble, C. O., Park, J. W., et al. (2006b). Genospheres: Self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery. Gene Therapy, 13, 646–651.
Hebert, C., Norris, K., Scheper, M. A., Nikitakis, N., & Sauk, J. J. (2007). High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Molecular Cancer, 6, 5.
Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., & Fuller, G. N. (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genetics, 25, 55–57.
Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., et al. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biology, 10, 202–210.
Huang, T. H., Wu, F., Loeb, G. B., Hsu, R., Heidersbach, A., Brincat, A., et al. (2009). Upregulation of miR-21 by HER2/neu signaling promotes cell invasion. Journal of Biological Chemistry, 284, 18515–18524.
Huse, J. T., Brennan, C., Hambardzumyan, D., Wee, B., Pena, J., Rouhanifard, S. H., et al. (2009). The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes and Development, 23, 1327–1337.
Jackson, E. L., & Alvarez-Buylla, A. (2008). Characterization of adult neural stem cells and their relation to brain tumors. Cells Tissues Organs, 188, 212–224.
Jackson, E. L., Garcia-Verdugo, J. M., Gil-Perotin, S., Roy, M., Quinones-Hinojosa, A., VandenBerg, S., et al. (2006). PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron, 51, 187–199.
James, C. D., & Cavenee, W. K. (2009). Stem cells for treating glioblastoma: how close to reality? Neuro-Oncology, 11, 101.
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., et al. (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635–647.
Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., et al. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes and Development, 19, 489–501.
Kanu, O. O., Mehta, A., Di, C., Lin, N., Bortoff, K., Bigner, D. D., et al. (2009). Glioblastoma multiforme: A review of therapeutic targets. Expert Opinion on Therapeutic Targets, 13, 701–718.
Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., Hawkinson, M., et al. (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Research, 68, 3566–3572.
Kuehbacher, A., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research, 101, 59–68.
Kuhnert, F., Mancuso, M. R., Hampton, J., Stankunas, K., Asano, T., Chen, C. Z., et al. (2008). Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development, 135, 3989–3993.
Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., et al. (2007). A microRNA signature of hypoxia. Molecular and Cellular Biology, 27, 1859–1867.
Kumar, M. S., Erkeland, S. J., Pester, R. E., Chen, C. Y., Ebert, M. S., Sharp, P. A., et al. (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proceedings of the National Academy of Sciences, USA, 105, 3903–3908.
Kumar, R., Gururaj, A. E., & Barnes, C. J. (2006). P21-activated kinases in cancer. Nature Reviews Cancer, 6, 459–471.
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., & Jacks, T. (2007). Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genetics, 39, 673–677.
Laws, E. R., Parney, I. F., Huang, W., Anderson, F., Morris, A. M., Asher, A., et al. (2003). Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. Journal of Neurosurgery, 99, 467–473.
le Sage, C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E., Mangiola, A., et al. (2007). Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO Journal, 26, 3699–3708.
Lee, E. J., Gusev, Y., Jiang, J., Nuovo, G. J., Lerner, M. R., Frankel, W. L., et al. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. International Journal of Cancer, 120, 1046–1054.
Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., et al. (2009a). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Letters, 275, 44–53.
Li, T., Li, D., Sha, J., Sun, P., & Huang, Y. (2009b). MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochemical and Biophysical Research Communications, 383, 280–285.
Li, W., & Szoka, F. C., Jr. (2007). Lipid-based nanoparticles for nucleic acid delivery. Pharmaceutical Research, 24, 438–449.
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica, 114, 97–109.
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834–838.
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setien, F., et al. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Research, 67, 1424–1429.
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682–688.
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007). The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Molecular Cell, 27, 435–448.
Medina, R., Zaidi, S. K., Liu, C. G., Stein, J. L., van Wijnen, A. J., Croce, C. M., et al. (2008). MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Research, 68, 2773–2780.
Melo, S. A., Ropero, S., Moutinho, C., Aaltonen, L. A., Yamamoto, H., Calin, G. A., et al. (2009). A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nature Genetics, 41, 365–370.
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., et al. (2006). Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 130, 2113–2129.
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., et al. (2008). Dicer, Drosha, and outcomes in patients with ovarian cancer. New England Journal of Medicine, 359, 2641–2650.
Miletic, H., Niclou, S. P., Johansson, M., & Bjerkvig, R. (2009). Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opinion on Therapeutic Targets, 13, 455–468.
Mischel, P. S., Cloughesy, T. F., & Nelson, S. F. (2004). DNA-microarray analysis of brain cancer: molecular classification for therapy. Nature Reviews Neuroscience, 5, 782–792.
Mizumatsu, S., Tamiya, T., Ono, Y., Abe, T., Matsumoto, K., Furuta, T., et al. (1999). Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma. Clinical Cancer Research, 5, 551–557.
Nelson, P. T., Baldwin, D. A., Kloosterman, W. P., Kauppinen, S., Plasterk, R. H., & Mourelatos, Z. (2006). RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA, 12, 187–191.
Nieder, C., Adam, M., Molls, M., & Grosu, A. L. (2006). Therapeutic options for recurrent high-grade glioma in adult patients: recent advances. Critical Reviews in Oncology/Hematology, 60, 181–193.
Okamoto, T., Sanda, T., & Asamitsu, K. (2007). NF-kappa B signaling and carcinogenesis. Current Pharmaceutical Design, 13, 447–462.
Otsuka, M., Zheng, M., Hayashi, M., Lee, J. D., Yoshino, O., Lin, S., et al. (2008). Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. Journal of Clinical Investigation, 118, 1944–1954.
Pallante, P., Visone, R., Ferracin, M., Ferraro, A., Berlingieri, M. T., Troncone, G., et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine-Related Cancer, 13, 497–508.
Panner, A., James, C. D., Berger, M. S., & Pieper, R. O. (2005). mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Molecular and Cellular Biology, 25, 8809–8823.
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008). MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research, 68, 8164–8172.
Piccirillo, S. G., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., et al. (2006). Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature, 444, 761–765.
Piva, R., Cavalla, P., Bortolotto, S., Cordera, S., Richiardi, P., & Schiffer, D. (1997). P27/kip1 expression in human astrocytic gliomas. Neuroscience Letters, 234, 127–130.
Powis, G., & Kirkpatrick, L. (2004). Hypoxia inducible factor-1alpha as a cancer drug target. Molecular Cancer Therapeutics, 3, 647–654.
Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J., & Yla-Herttuala, S. (2008). Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Letters, 582, 2397–2401.
Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., Sadoshima, J., et al. (2009). Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research, 104, 879–886.
Reddy, S. D., Ohshiro, K., Rayala, S. K., & Kumar, R. (2008). MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Research, 68, 8195–8200.
Rich, J. N., & Bao, S. (2007). Chemotherapy and cancer stem cells. Cell Stem Cell, 1, 353–355.
Rieger, J., Naumann, U., Glaser, T., Ashkenazi, A., & Weller, M. (1998). APO2 ligand: A novel lethal weapon against malignant glioma? FEBS Letters, 427, 124–128.
Saito, R., Krauze, M. T., Noble, C. O., Drummond, D. C., Kirpotin, D. B., Berger, M. S., et al. (2006). Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro-Oncology, 8, 205–214.
Sasayama, T., Nishihara, M., Kondoh, T., Hosoda, K., & Kohmura, E. (2009). MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. International Journal of Cancer, 125, 1407–1413.
Shi, L., Cheng, Z., Zhang, J., Li, R., Zhao, P., Fu, Z., et al. (2008). Hsa-Mir-181a and Hsa-Mir-181b function as tumor suppressors in human glioma cells. Brain Research, 1236, 185–193.
Shilo, S., Roy, S., Khanna, S., & Sen, C. K. (2008). Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 471–477.
Silber, J., Lim, D. A., Petritsch, C., Persson, A. I., Maunakea, A. K., Yu, M., et al. (2008). miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med, 6, 14.
Smirnova, L., Grafe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005). Regulation of miRNA expression during neural cell specification. European Journal of Neuroscience, 21, 1469–1477.
Sonoda, Y., Ozawa, T., Hirose, Y., Aldape, K. D., McMahon, M., Berger, M. S., et al. (2001). Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Research, 61, 4956–4960.
Suarez, Y., Fernandez-Hernando, C., Yu, J., Gerber, S. A., Harrison, K. D., Pober, J. S., et al. (2008). Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proceedings of the National Academy of Sciences, USA, 105, 14082–14087.
Sulman, E. P., Guerrero, M., & Aldape, K. (2009). Beyond grade: molecular pathology of malignant gliomas. Seminars in Radiation Oncology, 19, 142–149.
Taguchi, A., Yanagisawa, K., Tanaka, M., Cao, K., Matsuyama, Y., Goto, H., et al. (2008). Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Research, 68, 5540–5545.
Takata, H., Kato, M., Denda, K., & Kitamura, N. (2000). A hrs binding protein having a Src homology 3 domain is involved in intracellular degradation of growth factors and their receptors. Genes Cells, 5, 57–69.
van’t Veer, L. J., & Bernards, R. (2008). Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature, 452, 564–570.
Visvanathan, J., Lee, S., Lee, B., Lee, J. W., & Lee, S. K. (2007). The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes and Development, 21, 744–749.
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., et al. (2008a). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developmental Cell, 15, 261–271.
Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J. E., Baehner, L., & Blelloch, R. (2008b). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nature Genetics, 40, 1478–1483.
Wang, Y., Medvid, R., Melton, C., Jaenisch, R., & Blelloch, R. (2007). DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nature Genetics, 39, 380–385.
Webster, R. J., Giles, K. M., Price, K. J., Zhang, P. M., Mattick, J. S., & Leedman, P. J. (2009). Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. Journal of Biological Chemistry, 284, 5731–5741.
Weiss, W. A., Burns, M. J., Hackett, C., Aldape, K., Hill, J. R., Kuriyama, H., et al. (2003). Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Research, 63, 1589–1595.
Wu, L., & Belasco, J. G. (2005). Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Molecular and Cellular Biology, 25, 9198–9208.
Wu, H., Zhu, S., & Mo, Y. Y. (2009). Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Research, 19, 439–448.
Wurdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., et al. (2008). miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell, 14, 382–393.
Xia, H. F., He, T. Z., Liu, C. M., Cui, Y., Song, P. P., Jin, X. H., et al. (2009a). MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cellular Physiology and Biochemistry, 23, 347–358.
Xia, H., Qi, Y., Ng, S. S., Chen, X., Chen, S., Fang, M., et al. (2009b). MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochemical and Biophysical Research Communications, 380, 205–210.
Xia, H., Qi, Y., Ng, S. S., Chen, X., Li, D., Chen, S., et al. (2009c). microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Research.
Yamashita, Y., Krauze, M. T., Kawaguchi, T., Noble, C. O., Drummond, D. C., Park, J. W., et al. (2007). Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro-Oncology, 9, 20–28.
Yang, K., Handorean, A. M., & Iczkowski, K. A. (2009). MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. International Journal of Clinical and Experimental Pathology, 2, 361–369.
Yang, H., Kong, W., He, L., Zhao, J. J., O’Donnell, J. D., Wang, J., et al. (2008). MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research, 68, 425–433.
Yu, S. L., Chen, H. Y., Chang, G. C., Chen, C. Y., Chen, H. W., Singh, S., et al. (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48–57.
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., et al. (2006). Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Laboratory Investigation, 86, 1221–1232.
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000). Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer, 88, 2606–2618.
Zhang, Y., Chao, T., Li, R., Liu, W., Chen, Y., Yan, X., et al. (2009). MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. Journal of Molecular Medicine, 87, 43–51.
Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., et al. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Research, 59, 5830–5835.